24 ingrédients

CERAMIDE 1

Céramidesvérifié

Ceramide 1 (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where n has a value ranging from 10 to 20. The INCI Name, Ceramide 1, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 1 will be retained in the retired monograph, and also published with the new name assignment, Ceramide EOP.

Voir l’ingrédient

CERAMIDE 1 A

Céramides

Ceramide 1 A (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where n has a value ranging from 10 to 20. The INCI Name, Ceramide 1 A, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 1 A will be retained in the retired monograph, and also published with the new name assignment, Ceramide EOP.

Voir l’ingrédient

CERAMIDE 2

Céramides

Ceramide 2 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 14 to 28 and n has a value ranging from 10 to 16. The INCI Name, Ceramide 2, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 2 will be retained in the retired monograph, and also published with the new name assignment as either Ceramide NS or Ceramide NG.

Voir l’ingrédient

CERAMIDE 3

Céramidesvérifié

Ceramide 3 (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where m has a value ranging from 12 to 28 in which the acyl moiety may be saturated, mono-unsaturated, or di-unsaturated and n has a value ranging from 10 to 20. The INCI Name, Ceramide 3, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 3 will be retained in the retired monograph, and also published with the new name assignment, Ceramide NP.

Voir l’ingrédient

CERAMIDE 4

Céramidesvérifié

Ceramide 4 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsataurated and n has a value ranging from 10 to 16. Ceramide 4 is similar to Ceramide 5, however, the acylating hydroxy acids are generally shorter in Ceramide 4 than in Ceramide 5. The INCI Name, Ceramide 4, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 4 will be retained in the retired monograph, and also published with the new name assignment, Ceramide AS.

Voir l’ingrédient

CERAMIDE 5

Céramides

Ceramide 5 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsatuarated and n has a value ranging from 10 to 16. Ceramide 5 is similar to Ceramide 4, however, the acylating hydroxy acids are generally longer in Ceramide 5 than in Ceramide 4. The INCI Name, Ceramide 5, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 5 will be retained in the retired monograph, and also published with the new name assignment, Ceramide AS.

Voir l’ingrédient

CERAMIDE 6 II

Céramidesvérifié

Ceramide 6 II (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 and n has a value ranging from 12 to 20. The INCI Name, Ceramide 6 II, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 6 II will be retained in the retired monograph, and also published with the new name assignment, Ceramide AP.

Voir l’ingrédient

CERAMIDE AG

Céramidesvérifié

Ceramide AG is the N-acylated sphingolipid consisting of Sphinganine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.

Voir l’ingrédient

CERAMIDE AP

Céramidesvérifié

Ceramide AP, formerly known under the INCI name Ceramide 6 II, is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.

Voir l’ingrédient

CERAMIDE AS

Céramidesvérifié

Ceramide AS, formerly known under either of the INCI Names, Ceramide 4 or Ceramide 5, is the N-acylated sphingolipid consisting of sphingosine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.

Voir l’ingrédient

CERAMIDE ENP

Céramides

Ceramide ENP is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to normal saturated or unsaturated fatty acid which is esterified with saturated long (C14-C26) fatty acids in the 1-O-position.

Voir l’ingrédient

CERAMIDE EOG

Céramides

Ceramide EOG is the N-acylated sphingolipid consisting of Sphinganine having the D-erythro structure linked to an omega-hydroxy acid which is esterified with a saturated or unsaturated fatty acid.

Voir l’ingrédient

CERAMIDE EOP

Céramidesvérifié

Ceramide EOP, formerly known under either of the INCI Names, Ceramide 1 or Ceramide 1 A, is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to an omega-hydroxy acid which is esterified with a saturated or unsaturated fatty acid.

Voir l’ingrédient

CERAMIDE EOS

Céramidesvérifié

Ceramide EOS is a synthetic N-acylated sphingolipid consisting of Sphingosine having the D-erythro structure linked to an esterified omega-hydroxy saturated or unsaturated fatty acid

Voir l’ingrédient

CERAMIDE NG

Céramidesvérifié

Ceramide NG, formerly known under the INCI Name Ceramide 2, is the N-acylated sphingolipid consisting of Sphinganine having the D-erythro structure linked to a normal saturated or unsaturated fatty acid. As opposed to the broader definition for Ceramide 2 which includes sphingolipids consisting of either sphingosine or dihydrosphingosine (sphinganine), Ceramide NG is limited to sphinganine-based ceramides

Voir l’ingrédient

CERAMIDE NG DILAURATE

Céramides

Ceramide NG Dilaurate is the diester formed between Ceramide NG and Lauric Acid.

Voir l’ingrédient

CERAMIDE NP

Céramidesvérifié

Ceramide NP is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to normal saturated or unsaturated fatty acid.

Voir l’ingrédient

CERAMIDE NP OXOETHOXYDISULFIDE ACETYL ALANYL D-TETRAPEPTIDE-1 AMIDE

Céramides

Ceramide NP Oxoethoxydisulfide Acetyl Alanyl D-Tetrapeptide-1 Amide is prepared by reacting Ceramide NP and oxoethoxydisulfide with the product obtained by the acetylation of the synthetic peptide consisting of Alanine and D-Tetrapeptide-1 in which the C-terminus is an amide.

Voir l’ingrédient

CERAMIDE NP OXOETHOXYDISULFIDE ACETYL ALANYL D-TETRAPEPTIDE-1 AMIDES

Céramides

Ceramide NP Oxoethoxydisulfide Acetyl Alanyl D-Tetrapeptide-1 Amides is a mixture of mono-, di-, and tri-substituted compounds prepared by reacting Ceramide NP and oxoethoxydisulfide with the product obtained by the acetylation of the synthetic peptide consisting of Alanine and D-Tetrapeptide-1 in which the C-terminus is an amide.

Voir l’ingrédient

CERAMIDE NP STEARATE

Céramides

Ceramide NP Stearate is the product obtained by the reaction of Ceramide NP and Stearic Acid.

Voir l’ingrédient

CERAMIDE NS

Céramidesvérifié

Ceramide NS, formerly known under the INCI Name Ceramide 2, is the N-acylated sphingolipid consisting of sphingosine having the D-erythro structure linked to a normal saturated or unsaturated fatty acid. As opposed to the broader definition for Ceramide 2 which includes sphingolipids consisting of either sphingosine or dihydrosphingosine (sphinganine), Ceramide NS is limited to sphingosine-based ceramides.

Voir l’ingrédient

CERAMIDE NS DILAURATE

Céramides

Ceramide NS Dilaurate is the diester of Ceramide NS and lauric acid

Voir l’ingrédient

CERAMIDE NS/PEG-8/SUCCINIC ACID COPOLYMER

Céramides

Ceramide NS/PEG-8/Succinic Acid Copolymer is a copolymer of Ceramide NS, PEG-8 and Succinic Acid monomers

Voir l’ingrédient

CERAMIDE OP

Céramides

Ceramide OP is the organic compound that conforms to the formula, where n=5-15.

Voir l’ingrédient

Vous avez la liste complète des ingrédients ?

Collez-la dans l’analyseur INCI pour voir la fonction de chaque ingrédient.

Analyser les ingrédients